Title	Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial
Trial registration	ClinicalTrials.gov, ID: NCT04216420. Registered on 02 January 2020.
Protocol version:	04 December 2019, version 3
Funding:	The Fogarty International Center and National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health under Award Number D43TW009127. The research content is solely the responsibility of the authors and does not necessarily represent the official views of the U.S. National Institutes of Health.
Author details:	Tsegahun Manyazewal1*, Yimtubezinash Woldeamanuel1, David P. Holland2, Abebaw Fekadu1, Henry M. Blumberg2, Vincent C. Marconi2 1Addis Ababa University, College of Health Sciences, Center for Innovative Drug Development and Therapeutic Trials for Africa, Addis Ababa, Ethiopia 2Emory University School of Medicine and Rollins School of Public Health, Atlanta, Georgia, 30322, United States of America Study conception and Principal Investigator: TM. Initial study design and protocol: TM. Major contribution to study design and protocol: VCM, YW, DPH. Resource acquisition: HMB, AF. Draft the manuscript: TM. Reviewed and revised the manuscript: TM, VCM, YW, DPH, HMB, AF. Read and approved the final manuscript: TM, VCM, YW, DPH, HMB, AF.
Name and contact information for the trial sponsor:	Addis Ababa University - Email: health.sciences@aau.edu.et, Phone: +251118959055, website: www.aau.edu.et, P.O. Box: 9086, Addis Ababa, Ethiopia. The information and views set out in this study are those of the authors and do not necessarily reflect the official opinion of the Addis Ababa University